Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Masri

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Veterinary World|April 3, 2019
First report and molecular characterization of <i>Cryptosporidium</i> spp. in humans and animals in Khartoum state, SudanKaltoum Yagoub Adam, A A Ismail, M A Masri, et al.
Transplantation Proceedings|October 1, 1992
Cyclosporine dosage according to pharmacokinetic profiles leads to better graft and patient survival rates and a decrease in cyclosporine consumptionM A Masri, V S Dhawan, K Hayes, et al.
Transplantation Proceedings|December 5, 1998
A one-year comparative study of Neoral vs Consupren in de novo renal transplant patientsA Stephan, M A Masri, A Barbari, et al.
Transplantation Proceedings|November 20, 1997
Correlation between cyclosporine pharmacokinetics and immunologic parameters in dialyzed patients awaiting transplantationM A Masri, A Stephan, A Barbari, et al.
Transplantation Proceedings|August 11, 2001
Chronic graft dysfunction: donor factorsA Barbari, A Stephan, M A Masri, et al.
Transplantation Proceedings|August 11, 2001
Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?A Stephan, M A Masri, A Barbari, et al.
Transplantation Proceedings|December 20, 2000
Cyclosporine formulations: is there really a difference?M A Masri, A Stephan, A Barbari, et al.
Transplantation Proceedings|May 26, 2007
Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteersM A Masri, S Rizk, M L E Attia, et al.
Transplantation Proceedings|December 5, 1998
Measurement of lymphocyte cyclosporine levels in transplant patientsM A Masri, A Barbari, A Stephan, et al.
Transplantation Proceedings|November 20, 1997
A comparative study of HLA Allele frequency in Lebanese, Arabs, United Arab Emirates, and east Indian populationsM A Masri, A Stephan, A Barbari, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Veterinary World|April 3, 2019
First report and molecular characterization of <i>Cryptosporidium</i> spp. in humans and animals in Khartoum state, SudanKaltoum Yagoub Adam, A A Ismail, M A Masri, et al.
Transplantation Proceedings|October 1, 1992
Cyclosporine dosage according to pharmacokinetic profiles leads to better graft and patient survival rates and a decrease in cyclosporine consumptionM A Masri, V S Dhawan, K Hayes, et al.
Transplantation Proceedings|December 5, 1998
A one-year comparative study of Neoral vs Consupren in de novo renal transplant patientsA Stephan, M A Masri, A Barbari, et al.
Transplantation Proceedings|November 20, 1997
Correlation between cyclosporine pharmacokinetics and immunologic parameters in dialyzed patients awaiting transplantationM A Masri, A Stephan, A Barbari, et al.
Transplantation Proceedings|August 11, 2001
Chronic graft dysfunction: donor factorsA Barbari, A Stephan, M A Masri, et al.
Transplantation Proceedings|August 11, 2001
Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?A Stephan, M A Masri, A Barbari, et al.
Transplantation Proceedings|December 20, 2000
Cyclosporine formulations: is there really a difference?M A Masri, A Stephan, A Barbari, et al.
Transplantation Proceedings|May 26, 2007
Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteersM A Masri, S Rizk, M L E Attia, et al.
Transplantation Proceedings|December 5, 1998
Measurement of lymphocyte cyclosporine levels in transplant patientsM A Masri, A Barbari, A Stephan, et al.
Transplantation Proceedings|November 20, 1997
A comparative study of HLA Allele frequency in Lebanese, Arabs, United Arab Emirates, and east Indian populationsM A Masri, A Stephan, A Barbari, et al.
Pageof 6